{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T10:59:03Z","timestamp":1781089143472,"version":"3.54.1"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1,23]]},"abstract":"<jats:p>Surgery is one of the primary treatments for mid-to-late-stage endometrial cancer. However, patient responses to adjuvant therapy vary significantly, making the prediction of postoperative adjuvant therapy response crucial for these patients. This study aims to analyze the perioperative clinical and laboratory indicators of patients with mid- to late-stage endometrial cancer, identify key factors influencing the efficacy of adjuvant therapy, and construct a predictive model to provide a reference for clinical decision-making. This study retrospectively enrolled 260 mid-to-late-stage endometrial cancer patients who received postoperative adjuvant therapy and categorized them into effective and ineffective groups based on treatment response. Univariate analysis was performed to compare demographic and tumor characteristics between the 2 groups. Significant factors identified in the univariate analysis were classified into 2 categories (clinical variables and laboratory variables) and further analyzed using multivariate logistic regression and random forest analysis to identify the most influential predictors. A response prediction model was then constructed. Patients were stratified into high- and low-response groups based on the model\u2019s risk score for survival analysis. The effective group showed significantly better outcomes than the ineffective group in terms of obstetric history, FIGO stage, tumor grade, surgical approach, hospital stay, and postoperative complications. The final analysis identified the number of positive lymph nodes, high-risk histological type, surgical approach, albumin level, and neutrophil-to-lymphocyte ratio as the most significant predictive factors. The constructed response prediction model achieved an area under the curve of 0.795, with sensitivity and specificity of 0.799 and 0.670, respectively. The low-response group exhibited significantly worse overall survival and progression-free survival than the high-response group. By analyzing clinical and laboratory variables, this study identified key factors influencing the efficacy of postoperative adjuvant therapy in mid-to-late-stage endometrial cancer patients and developed a predictive model with strong discriminative ability. The findings may provide valuable references for individualized clinical treatment and help improve patient prognosis.<\/jats:p>","DOI":"10.1097\/md.0000000000046642","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T18:01:22Z","timestamp":1769191282000},"page":"e46642","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Prediction of postoperative adjuvant therapy efficacy based on perioperative indicators in patients with mid- to late-stage endometrial cancer"],"prefix":"10.1097","volume":"105","author":[{"given":"Caijun","family":"He","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynaecology, The 962 Hospital, Joint Logistic Support of the Chinese People\u2019s Liberation Army, Harbin City, Heilongjiang Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhe","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, The 962 Hospital, Joint Logistic Support of the Chinese People\u2019s Liberation Army, Harbin City, Heilongjiang Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huizi","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, The 962 Hospital, Joint Logistic Support of the Chinese People\u2019s Liberation Army, Harbin City, Heilongjiang Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liying","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, The 962 Hospital, Joint Logistic Support of the Chinese People\u2019s Liberation Army, Harbin City, Heilongjiang Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhili","family":"Dai","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, The 962 Hospital, Joint Logistic Support of the Chinese People\u2019s Liberation Army, Harbin City, Heilongjiang Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7254-740X","authenticated-orcid":false,"given":"Shuang","family":"Han","sequence":"additional","affiliation":[{"name":"Department of anesthesiology, The 962 Hospital, Joint Logistic Support of the Chinese People\u2019s Liberation Army, Harbin City, Heilongjiang Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260610","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0140-6736(05)67063-8","article-title":"Endometrial cancer.","volume":"366","author":"Amant","year":"2005","journal-title":"Lancet"},{"key":"R2-20260610","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41572-021-00324-8","article-title":"Endometrial cancer.","volume":"7","author":"Makker","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"R3-20260610","doi-asserted-by":"crossref","first-page":"e080978","DOI":"10.1136\/bmj-2024-080978","article-title":"Advances in the management of endometrial cancer.","volume":"388","author":"Corr","year":"2025","journal-title":"Bmj"},{"key":"R4-20260610","doi-asserted-by":"crossref","first-page":"105159","DOI":"10.1016\/j.ebiom.2024.105159","article-title":"Endometrial cancer: improving management among increasing incidence rates.","volume":"103","year":"2024","journal-title":"EBioMedicine"},{"key":"R5-20260610","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ygyno.2024.02.002","article-title":"2023 FIGO staging system for endometrial cancer: the evolution of the revolution.","volume":"184","author":"Gaffney","year":"2024","journal-title":"Gynecol Oncol"},{"key":"R6-20260610","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/ijgc-2024-005567","article-title":"2009 international federation of gynecology and obstetrics (FIGO) stage IIIA endometrial cancer: oncologic outcomes based on involvement of adnexa, serosa, or both.","volume":"34","author":"Rios-Doria","year":"2024","journal-title":"Int J Gynecol Cancer"},{"key":"R7-20260610","doi-asserted-by":"crossref","first-page":"101773","DOI":"10.1016\/j.ijgc.2025.101773","article-title":"International federation of gynecology and obstetrics 2023 stage IIIB2 endometrial cancer with pelvic peritoneal metastasis: assessment of adjuvant therapy effect on survival.","volume":"35","author":"Matsuo","year":"2025","journal-title":"Int J Gynecol Cancer"},{"key":"R8-20260610","first-page":"45","article-title":"Surgical staging in endometrial cancer.","volume":"20","author":"Kirby","year":"2006","journal-title":"Oncology (Williston Park)"},{"key":"R9-20260610","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.ygyno.2003.12.001","article-title":"Total laparoscopic hysterectomy for endometrial cancer: patterns of recurrence and survival.","volume":"92","author":"Obermair","year":"2004","journal-title":"Gynecol Oncol"},{"key":"R10-20260610","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.jmig.2014.12.003","article-title":"Robotic single-port hysterectomy, adnexectomy, and lymphadenectomy in endometrial cancer.","volume":"22","author":"Yoon","year":"2015","journal-title":"J Minim Invasive Gynecol"},{"key":"R11-20260610","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/CCO.0000000000000558","article-title":"Adjuvant treatment for endometrial cancer.","volume":"31","author":"Emons","year":"2019","journal-title":"Curr Opin Oncol"},{"key":"R12-20260610","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1136\/ijgc-2020-001446","article-title":"Role of adjuvant therapy in stage IIIC2 endometrial cancer.","volume":"30","author":"Bogani","year":"2020","journal-title":"Int J Gynecol Cancer"},{"key":"R13-20260610","doi-asserted-by":"crossref","first-page":"5632","DOI":"10.3390\/cancers14225632","article-title":"Nomograms based on fibrinogen, albumin, neutrophil-lymphocyte ratio, and carbohydrate antigen 125 for predicting endometrial cancer prognosis.","volume":"14","author":"Li","year":"2022","journal-title":"Cancers (Basel)"},{"key":"R14-20260610","doi-asserted-by":"crossref","first-page":"3712","DOI":"10.7150\/ijms.64658","article-title":"Preoperative neutrophil-to-lymphocyte, platelet-to-lymphocyte and monocyte-to-lymphocyte ratio as a prognostic factor in non-endometrioid endometrial cancer.","volume":"18","author":"Song","year":"2021","journal-title":"Int J Med Sci"},{"key":"R15-20260610","doi-asserted-by":"crossref","first-page":"181","DOI":"10.6004\/jnccn.2023.0006","article-title":"Uterine neoplasms, version 1.2023, NCCN clinical practice guidelines in oncology.","volume":"21","author":"Abu-Rustum","year":"2023","journal-title":"J Natl Compr Canc Netw"},{"key":"R16-20260610","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejca.2016.03.081","article-title":"RECIST 1.1-update and clarification: from the RECIST committee.","volume":"62","author":"Schwartz","year":"2016","journal-title":"Eur J Cancer"},{"key":"R17-20260610","doi-asserted-by":"crossref","first-page":"1449291","DOI":"10.3389\/fimmu.2024.1449291","article-title":"Lymphatic system regulation of anti-cancer immunity and metastasis.","volume":"15","author":"Lei","year":"2024","journal-title":"Front Immunol"},{"key":"R18-20260610","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12943-021-01489-2","article-title":"Combination strategies with PD-1\/PD-L1 blockade: current advances and future directions.","volume":"21","author":"Yi","year":"2022","journal-title":"Mol Cancer"},{"key":"R19-20260610","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1080\/14728222.2020.1744568","article-title":"TGF-beta: a master immune regulator.","volume":"24","author":"Larson","year":"2020","journal-title":"Expert Opin Ther Targets"},{"key":"R20-20260610","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ygyno.2021.04.029","article-title":"Uterine serous carcinoma.","volume":"162","author":"Bogani","year":"2021","journal-title":"Gynecol Oncol"},{"key":"R21-20260610","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ygyno.2022.06.004","article-title":"Minimally invasive surgery versus open surgery in high-risk histologic endometrial cancer patients: a meta-analysis.","volume":"166","author":"Kim","year":"2022","journal-title":"Gynecol Oncol"},{"key":"R22-20260610","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s00228-024-03664-y","article-title":"Albumin: a comprehensive review and practical guideline for clinical use.","volume":"80","author":"Abedi","year":"2024","journal-title":"Eur J Clin Pharmacol"},{"key":"R23-20260610","doi-asserted-by":"crossref","first-page":"dju124","DOI":"10.1093\/jnci\/dju124","article-title":"Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis.","volume":"106","author":"Templeton","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"R24-20260610","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/nri.2017.105","article-title":"Neutrophil extracellular traps in immunity and disease.","volume":"18","author":"Papayannopoulos","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"R25-20260610","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1067\/mob.2000.106251","article-title":"Preoperative CA 125 in endometrial cancer: is it useful?","volume":"182","author":"Dotters","year":"2000","journal-title":"Am J Obstet Gynecol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046642","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T10:01:57Z","timestamp":1781085717000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046642"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000046642","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,23]]},"assertion":[{"value":"2025-08-23","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-27","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}